Background: Ki-67 is a typical immunohistochemical marker for cell proliferation. Higher
expression of Ki-67 is correlated with poor clinical outcomes in several cancers. However …

Canine brain tumours are becoming established as naturally occurring models of disease to
advance diagnostic and therapeutic understanding successfully. The size and structure of …

Objective: Meningiomas presented preferred intracranial distribution, which may reflect
potential biological natures. This study aimed to analyze the preferred locations of …

OBJECTIVE Ki-67 immunohistochemistry is widely used as a prognostic marker in
meningiomas, but visual estimations tend to be imprecise. Whether the average Ki-67 over …

The HLA-G and HLA-E molecules, Ki67, progesterone (PR), estrogen (ER) and androgen
receptors (AR), p53, COX-2, and HER2 were studied to assess whether the biological …

Introduction Despite optimal surgical resection, meningiomas may recur, with increasing
grade and the degree of resection being predictive of risk. We hypothesize that an …

Simple Summary The World Health Organization (WHO) classification grades meningiomas
exclusively due to their histopathological features. Meningiomas are predominantly benign …

Purpose To investigate the utility of preoperative multiparametric magnetic resonance
imaging (mpMRI)-based clinical-radiomic analysis combined with machine learning (ML) …

Simple Summary Meningiomas are predominantly benign intracranial tumors, and surgical
therapy represents the treatment of choice. However, the risk of recurrence and scheduling …

Objective We conducted this study with the aim of predicting the biological behavior of
meningiomas, and determining the benefits of associating histological subtype and grade …